Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
12126
PUT
DELISTED
Centessa Pharmaceuticals
CNTA
| $31.8K | ﹤0.01% |
4,000
+1,900
| +90% | +$12.7K |
|
12127
CALL
International Seaways
INSW
$4.81B
| $31.8K | ﹤0.01% |
700
-20,900
| -97% | -$961K |
|
12128
PUT
Vinci Compass Investments Ltd
VINP
$626M
| $31.8K | ﹤0.01% |
2,900
+1,100
| +61% | +$11.3K |
|
12129
PUT
Simmons First National
SFNC
$3.48B
| $31.7K | ﹤0.01% |
1,600
-1,300
| -45% | -$21.8K |
|
|
LYT
12130
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
| $31.7K | ﹤0.01% |
+4,760
| New | +$40.7K |
|
12131
CALL
eGain
EGAN
$206M
| $31.7K | ﹤0.01% |
3,800
+2,300
| +153% | +$16.2K |
|
12132
CALL
TransAlta
TAC
$4.05B
| $31.6K | ﹤0.01% |
3,800
-20,500
| -84% | -$166K |
|
12133
PUT
Medallion Financial
MFIN
$264M
| $31.5K | ﹤0.01% |
3,200
-68,500
| -96% | -$569K |
|
12134
ABVC BioPharma
ABVC
$24M
| $31.5K | ﹤0.01% |
27,158
+11,567
| +74% | +$13.6K |
|
12135
PUT
Amtech Systems
ASYS
$281M
| $31.5K | ﹤0.01% |
7,500
+4,700
| +168% | +$31.9K |
|
12136
PUT
Central Pacific Financial
CPF
$996M
| $31.5K | ﹤0.01% |
1,600
+1,300
| +433% | +$22.7K |
|
|
IMMP
12137
PUT
Immutep
IMMP
$56M
| $31.4K | ﹤0.01% |
13,100
-3,300
| -20% | -$6.52K |
|
|
AHT
12138
CALL
Ashford Hospitality Trust
AHT
$20.8M
| $31.4K | ﹤0.01% |
1,620
| – | – |
|
|
MFA
12139
MFA Financial
MFA
$926M
| $31.3K | ﹤0.01% |
+2,780
| New | +$28.1K |
|
|
PBLA
12140
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
| $31.3K | ﹤0.01% |
1,711
-82
| -5% | -$1.28K |
|
12141
PUT
Zedge
ZDGE
$38.4M
| $31.3K | ﹤0.01% |
13,300
+4,600
| +53% | +$9.22K |
|
12142
PUT
Porch Group
PRCH
$1.97B
| $31.1K | ﹤0.01% |
10,100
-12,000
| -54% | -$16.9K |
|
12143
PUT
Geospace Technologies
GEOS
$72.4M
| $31.1K | ﹤0.01% |
2,400
-1,600
| -40% | -$19.6K |
|
|
CLDT
12144
PUT
Chatham Lodging
CLDT
$605M
| $31.1K | ﹤0.01% |
2,900
-100
| -3% | -$999 |
|
12145
PUT
Absci
ABSI
$1.58B
| $31.1K | ﹤0.01% |
7,400
-7,000
| -49% | -$13K |
|
12146
CALL
nLIGHT
LASR
$3.03B
| $31.1K | ﹤0.01% |
2,300
+200
| +10% | +$2.24K |
|
12147
PUT
Universal Electronics
UEIC
$67.9M
| $31K | ﹤0.01% |
3,300
-1,200
| -27% | -$9.81K |
|
12148
CALL
Jasper Therapeutics
JSPR
$26.3M
| $30.9K | ﹤0.01% |
3,920
-2,970
| -43% | -$19.9K |
|
12149
CALL
Westwater Resources
WWR
$72.7M
| $30.9K | ﹤0.01% |
54,700
-300
| -0.5% | -$181 |
|
12150
PUT
BioLife Solutions
BLFS
$1.72B
| $30.9K | ﹤0.01% |
1,900
+100
| +6% | +$1.28K |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.